Ausgabe 11/2014
Inhalt (12 Artikel)
A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response
Jason W.-L. Eng, Kathleen M. Kokolus, Chelsey B. Reed, Bonnie L. Hylander, Wen W. Ma, Elizabeth A. Repasky
Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours
Anna St. Swierzko, Agnieszka Szala, Sambor Sawicki, Janusz Szemraj, Marcin Sniadecki, Anna Sokolowska, Andrzej Kaluzynski, Dariusz Wydra, Maciej Cedzynski
AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction
Sonia A. Perez, Eleftheria A. Anastasopoulou, Michael Papamichail, Constantin N. Baxevanis
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
Tim Luetkens, Sebastian Kobold, Yanran Cao, Marina Ristic, Georgia Schilling, Sinje Tams, Britta Marlen Bartels, Julia Templin, Katrin Bartels, York Hildebrandt, Sara Yousef, Andreas Marx, Friedrich Haag, Carsten Bokemeyer, Nicolaus Kröger, Djordje Atanackovic
A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control
Jennifer D. Stone, Daniel T. Harris, Carolina M. Soto, Adam S. Chervin, David H. Aggen, Edward J. Roy, David M. Kranz
Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer
Manja Idorn, Tania Køllgaard, Per Kongsted, Lisa Sengeløv, Per thor Straten
FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4+ T regulatory cells
Walter Moises Tobias Braga, Bruna Raphaeli da Silva, Ana Carolina de Carvalho, Yumi H. Maekawa, Adriana Bruscato Bortoluzzo, Edgar Gil Rizzatti, Djordje Atanackovic, Gisele Wally Braga Colleoni
Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining
Lindsey Chudley, Katy J. McCann, Adam Coleman, Angelica M. Cazaly, Nicole Bidmon, Cedrik M. Britten, Sjoerd H. van der Burg, Cecile Gouttefangeas, Camilla Jandus, Karoline Laske, Dominik Maurer, Pedro Romero, Helene Schröder, Linda F. M. Stynenbosch, Steffen Walter, Marij J. P. Welters, Christian H. Ottensmeier
CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma
Britnie R. James, Kristin G. Anderson, Erik L. Brincks, Tamara A. Kucaba, Lyse A. Norian, David Masopust, Thomas S. Griffith
Fast-growing in-transit melanoma metastasis after intratumoral interleukin-2
David Moreno-Ramírez, Martina Alés-Martínez, Lara Ferrándiz
Limited efficacy of intratumoral IL-2 applied to large melanoma metastases
Benjamin Weide, Thomas Kurt Eigentler, Giuliano Elia, Dario Neri, Claus Garbe
Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma
Ester Simeone, Giusy Gentilcore, Diana Giannarelli, Antonio M. Grimaldi, Corrado Caracò, Marcello Curvietto, Assunta Esposito, Miriam Paone, Marco Palla, Ernesta Cavalcanti, Fabio Sandomenico, Antonella Petrillo, Gerardo Botti, Franco Fulciniti, Giuseppe Palmieri, Paola Queirolo, Paolo Marchetti, Virginia Ferraresi, Gaetana Rinaldi, Maria Pia Pistillo, Gennaro Ciliberto, Nicola Mozzillo, Paolo A. Ascierto